High-Risk Flu Vaccine

7110 Forest Avenue, STE 201, Richmond, VA 23226
Summary
Clinical Research Partners is enrolling adults for an influenza vaccine research study. Eligible participants include adults ages 12–64 with a high-risk medical condition or adults ages 65 and older. The study includes one dose of the study vaccine or a licensed influenza vaccine and a six-month commitment.
Age
12–64 years old with a high-risk medical condition OR 65 years and older

Meet Our Team

Our experienced team will guide you through the process

Dr. Call, co-founder of Clinical Research Partners, serves as President. He is a Certified Principle Investigator

Robert S. Call, MD, CPI

President

Annette Bennett, co-founder of Clinical Research Partners, serves as Chief Executive Officer and Research Director. She

Annette Bennett

Chief Executive Officer

Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a

Bo Vaughan, MD, MSHA, CPI

Medical Director

Mimi Franzen Canada

Chief Operations Officer

Jeanette Weller

EVP of Contracts and Budgets

Caitlin Vining

Controller CCRP

Kelly Craighead, BS, RN, CCRC

Regulatory Affairs Director

Carly McLaughlin, PharmD

Director of Pharmacy PharmD

Lisa Smith, BSN, RN

Director of Quality Assurance

Joy Walker

Director of Business Development

Aundraya Bray, LCSW

Clinical Operations Coordinator

Shawn Mease, CCRC, NRP, CCEMT-P

Director of Study Start-Up